MSD Executive Shows MEPs How Brexit Will Hit Pharma Supply Chains
Executive Summary
A senior MSD executive has outlined the impact that Brexit could have on global supply chains, regulatory cooperation and research, at a hearing of the European Parliament’s ENVI committee. Another UK parliamentary committee is to hear industry’s concerns on Dec. 5.